Goldman Sachs asks in biotech Report: Is curing patients a sustainable business? (2018)
randycupertino Sunday, November 16, 2025
Summary
The article discusses concerns raised by Goldman Sachs about the potential impact of new highly effective medical treatments on the pharmaceutical industry's business model, as curing diseases could reduce long-term revenue compared to managing chronic conditions.
243
177
Summary
cnbc.com